ArticleDiabetes technology & therapeutics2023
Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial.
Registry-linked trialOpen access · hybridAbstract readMulticenter Study
In one paragraph
Article in Diabetes technology & therapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07645079 (Inpatient Diabetes Management With Automated Insulin Delivery Systems Compared to Multiple Daily Injections With a Basal-bolus Regimen - a Randomized Controlled Trial), which is not on this map. Cited by 21 papers.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Inpatient Diabetes Management With Automated Insulin Delivery Systems Compared to Multiple Daily Injections With a Basal-bolus Regimen - a Randomized Controlled Trial
Who cites it
21 citing papers in PubMed, 30 citations in OpenAlex.
- Results From a Randomized Trial of Intensive Glucose Management Using CGM Versus Usual Care in Hospitalized Adults With Type 2 Diabetes: The TIGHT Study.Diabetes care · 2025Trial
- An international position statement on practical approaches for inpatient continuous glucose monitoring, insulin pumps and automated insulin delivery systems in adults.Diabetologia · 2026Article
- Article
- Algorithm-guided insulin therapy in hospitalized patients: current evidence, implementation challenges, and future perspectives.Reviews in endocrine & metabolic disorders · 2026Review
- The Development of a Syringe-Based Insulin Applicator Using a Biodesign-Based Methodology.Biomimetics (Basel, Switzerland) · 2026Article
- Accuracy and reliability of a continuous glucose monitoring system with a focus on hypoglycaemia.Diabetes, obesity & metabolism · 2026Article
- Inpatient Use of Automated Insulin Delivery Systems.Journal of diabetes science and technology · 2026Review
- Implementing a Continuous Glucose Monitoring Hospital Discharge Program: Strategies and Best Practices.Journal of diabetes science and technology · 2026Article
- 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2026.Diabetes care · 2026Review
- Advances in the management of hyperglycaemia and diabetes mellitus during hospitalization.Nature reviews. Endocrinology · 2025Review
- Recurrent education: A promising strategy for enhancing diabetes management and reducing hypoglycemia in children with type 1 diabetes.BMC endocrine disorders · 2025Article
- Toward Automation: The Road Traveled and Road Ahead for Integrating Automated Insulin Delivery into Inpatient Care.Diabetes technology & therapeutics · 2025Review
- Future horizons in diabetes: integrating AI and personalized care.Frontiers in endocrinology · 2025Review
- Automated Insulin Delivery for Type 1 Diabetes: Present and Future.Diabetes spectrum : a publication of the American Diabetes Association · 2025Article
- Development of a Real-time Force-based Algorithm for Infusion Failure Detection.Journal of diabetes science and technology · 2024Article
- Technology in the management of diabetes in hospitalised adults.Diabetologia · 2024Review
- Empowering Hospitalized Patients With Diabetes: Implementation of a Hospital-wide CGM Policy With EHR-Integrated Validation for Dosing Insulin.Diabetes care · 2024Article
- Review Article - Diabetes Technology in the Hospital: An Update.Current diabetes reports · 2024Review
- Reducing Inequity in the Use of Automated Insulin Delivery Systems by Adults With Type 1 Diabetes: Key Learnings From a Safety Net Diabetes Clinic Program.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2024Article
- Digital Technology for Diabetes.The New England journal of medicine · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors at 5 institutions in 1 country.
Georgia M DavisDivision of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Michael S HughesDivision of Endocrinology, Gerontology and Metabolism, Department of Medicine, Stanford University, Stanford, California, USA.ORCID 0000-0002-3729-0350
Sue A BrownDivision of Endocrinology, Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
Judy SibayanJaeb Center for Health Research, Tampa, Florida, USA.
M Citlalli Perez-GuzmanDivision of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Meaghan StumpfDivision of Endocrinology, Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
Zachary ThompsonJaeb Center for Health Research, Tampa, Florida, USA.
Marina BasinaDivision of Endocrinology, Gerontology and Metabolism, Department of Medicine, Stanford University, Stanford, California, USA.
Ronak M PatelDivision of Endocrinology, Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
Joi HesterDivision of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Amalia AbrahamDivision of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Trang T LyInsulet Corporation, Acton, Massachusetts, USA.ORCID 0000-0002-5995-1447
Cherie ChaneyDivision of Endocrinology, Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
Marilyn TanDivision of Endocrinology, Gerontology and Metabolism, Department of Medicine, Stanford University, Stanford, California, USA.
Liana HsuDivision of Pediatric Endocrinology, Department of Pediatrics, Stanford University, Stanford, California, USA.
Craig KollmanJaeb Center for Health Research, Tampa, Florida, USA.
Roy W BeckJaeb Center for Health Research, Tampa, Florida, USA.ORCID 0000-0002-5194-8446
Rayhan LalDivision of Endocrinology, Gerontology and Metabolism, Department of Medicine, Stanford University, Stanford, California, USA.ORCID 0000-0002-8055-944X
Bruce BuckinghamDivision of Pediatric Endocrinology, Department of Pediatrics, Stanford University, Stanford, California, USA.
Francisco J PasquelDivision of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-3845-6703
Stanford Medicine · USEmory University · USJaeb Center for Health Research · USUniversity of Virginia · USInsulet (United States) · US
Funding
Stanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI Seung K Kim · 2017 to 2026
$19.5MTranslational Research Core - Engagement and Behavior ChangeP30DK111024 · NIDDK · EMORY UNIVERSITY · PI Mohammed Kumail Ali · 2016 to 2026
$13.4MDiabetes, Endocrinology and Metabolism Training GrantT32DK007217 · NIDDK · STANFORD UNIVERSITY · PI Justin Pierce Annes, David Matthew Maahs · 1987 to 2026
$7.2MTraining Research Leaders in Type 1 DiabetesK12DK122550 · NIDDK · STANFORD UNIVERSITY · PI MAAHS, DAVID MATTHEW · 2019 to 2023
$2.1MThe Optimal Pathway to Implanted Autonomous Insulin DeliveryK23DK122017 · NIDDK · STANFORD UNIVERSITY · PI LAL, RAYHAN · 2020 to 2024
$958kMetabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery PatientsK23GM128221 · NIGMS · EMORY UNIVERSITY · PI PASQUEL, FRANCISCO J · 2018 to 2022
$957kPerioperative Stress Hyperglycemia in General and Vascular Surgery PatientsK23DK122199 · NIDDK · EMORY UNIVERSITY · PI DAVIS, GEORGIA M · 2020 to 2024
$891kNIDDK NIH HHS K12 DK122550NIDDK NIH HHS K23 DK122017NIDDK NIH HHS K23 DK122199NIDDK NIH HHS P30 DK111024NIDDK NIH HHS P30 DK116074NIDDK NIH HHS T32 DK007217NIGMS NIH HHS K23 GM128221
Abstract
PubMed holds no abstract for this paper.
Indexed as
Diabetes Mellitus, Type 1Diabetic KetoacidosisHypoglycemiaBlood GlucoseBlood Glucose Self-MonitoringFeasibility StudiesHumansHypoglycemic AgentsInsulinInsulin Infusion SystemsInsulin, Regular, HumanPilot ProjectsBlood GlucoseHypoglycemic AgentsInsulinInsulin, Regular, HumanAutomated insulin deliveryHybrid closed-loopInpatient diabetes
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
NCT07645079ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.